Metabolism News and Research

Latest Metabolism News and Research

Gene therapy improves chylomicron metabolism in LPLD patients

Amsterdam Molecular Therapeutics, a leader in the field of human gene therapy, announced today data demonstrating that one-time administration of the gene therapy Glybera (alipogene tiparvovec) is able to markedly improve chylomicron (fat particles in the blood) metabolism following consumption of a low fat meal.

29 Mar 2012

Meditation decreases depression, anxiety and stress in school teachers

Schoolteachers who underwent a short but intensive program of meditation were less depressed, anxious or stressed - and more compassionate and aware of others' feelings, according to a UCSF-led study that blended ancient meditation practices with the most current scientific methods for regulating emotions.

29 Mar 2012

EU's Safety Evaluation Ultimately Replacing Animal Testing initiative tests Roche's xCELLigence system

Roche's xCELLigence RTCA System is being used in the European Union's SEURAT (Safety Evaluation Ultimately Replacing Animal Testing) initiative to run five years from 2011 to 2016.

From Roche Sequencing and Life Science 29 Mar 2012

Interleukin, U-M School of Dentistry complete enrollment in PST Genetic Test study

The University of Michigan School of Dentistry and Interleukin Genetics, Inc. announced today the completion of patient enrollment for a landmark clinical study using Interleukin's PST Genetic Test to determine if dental patients can be risk-stratified to guide frequency of preventive dental visits and reduce the adverse outcomes of periodontal disease progression, such as tooth loss.

29 Mar 2012

Inhibitory control test and lactulose for MHE saves more than $3 million over 5 years

A late stage liver condition, known as minimal hepatic encephalopathy (MHE), is associated with impaired driving skills and greater risk of motor vehicle accidents. Cost analysis of management strategies for detection and treatment of MHE are published in the April issue of Hepatology, a journal of the American Association for the Study of Liver Diseases.

29 Mar 2012

Understanding quantum metabolism may help stop cancer growth

The theory of quantum metabolism is the idea that quantum processes, such as entanglement, influence the metabolism of cells. This idea offers scientists a new explanation for the metabolic changes that cause healthy cells to transform into cancerous ones. The metamorphosis gives cancerous cells the ability to outcompete healthy cells for space and nutrients, causing the disease to spread.

28 Mar 2012

Hyperinsulinemia itself not a cause of atherosclerosis

A number of studies have shown that excess insulin circulating in the bloodstream is a major independent risk factor for cardiovascular disease. However, a new study from Joslin Diabetes Center finds that this condition, called hyperinsulinemia, is itself not a cause of atherosclerosis.

28 Mar 2012

CSEP develops two guidelines to improve health and activity levels of infants, toddlers

In response to an urgent call from public health, health care, child care, and fitness practitioners, the Canadian Society for Exercise Physiology (CSEP), with assistance from multiple partners, has developed two important sets of guidelines directed at improving the health and activity levels of infants and toddlers.

28 Mar 2012

New pre-clinical data on Rexahn's RX-3117 study to be presented at AACR meeting

Rexahn Pharmaceuticals, Inc., a clinical stage pharmaceutical company commercializing potential best in class oncology and CNS therapeutics, today announced that it will present new pre-clinical data on its oncology compound RX-3117 during a poster session at the American Association for Cancer Research (AACR) 103rd Annual Meeting being held in Chicago, Illinois, March 31 - April 4, 2012, at the McCormick Place Convention Center.

28 Mar 2012

UT Southwestern researcher wins prestigious award from International Atherosclerosis Society

Dr. Helen Hobbs, a preeminent researcher on the genetics of cholesterol metabolism at UT Southwestern Medical Center, has won a prestigious award from the International Atherosclerosis Society.

28 Mar 2012

Researchers develop gut-on-a-chip microdevice

Researchers at the Wyss Institute for Biologically Inspired Engineering at Harvard University have created a gut-on-a-chip microdevice lined by living human cells that mimics the structure, physiology, and mechanics of the human intestine-even supporting the growth of living microbes within its luminal space.

28 Mar 2012

UC professor to show new anticancer agent at ACS Spring 2012 meeting

Advances in chemotherapy have dramatically improved the outlook for many cancer patients, but the side effects of this treatment are daunting. A new generation of chemotherapy drugs with fewer side effects is the goal of Edward J. Merino, assistant professor of chemistry at the University of Cincinnati.

27 Mar 2012

Obese youths with particular genetic variants may be more prone to fatty liver disease

Obese youths with particular genetic variants may be more prone to fatty liver disease, a leading cause of chronic liver disease in children and adolescents in industrialized countries, according to new findings by Yale School of Medicine researchers.

27 Mar 2012

First study to explore differential gender effects of secondhand smoke exposure

The negative health effects of early-life exposure to secondhand smoke appear to impact girls more than boys-particularly those with early-life allergic sensitization, according to new research from the University of Cincinnati (UC) College of Medicine.

27 Mar 2012

EMA accepts Arena's lorcaserin MAA for weight control

Arena Pharmaceuticals, Inc. announced today that the European Medicines Agency (EMA) has accepted the filing of a Marketing Authorization Application (MAA) for lorcaserin, an investigational drug candidate intended for weight control, including weight loss and maintenance of weight loss, in patients who are obese (BMI >30) or patients who are overweight (BMI >27) and have at least one weight-related co-morbid condition.

26 Mar 2012

Promising results from Esperion ETC-1002 Phase 2 clinical trial for dyslipidemia

Esperion Therapeutics, a privately held biotechnology company working to discover, develop and commercialize treatments for cardiovascular and metabolic diseases, today announced positive results from a Phase 2 clinical trial for ETC-1002.

26 Mar 2012

Switch may release fuel and materials for rapid growth and formation of layers that later become organs

Shortly after a mouse embryo starts to form, some of its stem cells undergo a dramatic metabolic shift to enter the next stage of development, Seattle researchers report today. These stem cells start using and producing energy like cancer cells.

26 Mar 2012

ETC-1002 drug reduces LDL cholesterol levels in hypercholesterolemic patients

Early data suggest ETC-1002, a drug that regulates lipid and carbohydrate metabolism, had a significant impact on cholesterol levels and improved factors believed to contribute to cardio-metabolic diseases, say researchers from the Methodist DeBakey Heart & Vascular Center, the Baylor College of Medicine, and Esperion Therapeutics, Inc., who are presenting their work at the 2012 American College of Cardiology Scientific Session in Chicago.

26 Mar 2012

High-fat, low-carb foods linked with increased risk of heart attack in obese people

High-fat, low-carb foods are a popular choice for dieters, but new laboratory research by University of Alabama at Birmingham cardiologists indicates these may be detrimental to the health of people who have ischemic cardiovascular disease or a predisposition to heart attacks.

26 Mar 2012

Long daily sedentary periods cause a health risk despite physical activity

Good physical condition is a route to better health, and in order to improve it, exercising several days a week is recommended. Although it is possible to become healthier by exercising, long daily sedentary periods cause a health risk despite physical activity.

23 Mar 2012

Metabolism News and Research

Latest Metabolism News and Research

Gene therapy improves chylomicron metabolism in LPLD patients

Meditation decreases depression, anxiety and stress in school teachers

EU's Safety Evaluation Ultimately Replacing Animal Testing initiative tests Roche's xCELLigence system

Interleukin, U-M School of Dentistry complete enrollment in PST Genetic Test study

Inhibitory control test and lactulose for MHE saves more than $3 million over 5 years

Understanding quantum metabolism may help stop cancer growth

Hyperinsulinemia itself not a cause of atherosclerosis

CSEP develops two guidelines to improve health and activity levels of infants, toddlers

New pre-clinical data on Rexahn's RX-3117 study to be presented at AACR meeting

UT Southwestern researcher wins prestigious award from International Atherosclerosis Society

Researchers develop gut-on-a-chip microdevice

UC professor to show new anticancer agent at ACS Spring 2012 meeting

Obese youths with particular genetic variants may be more prone to fatty liver disease

First study to explore differential gender effects of secondhand smoke exposure

EMA accepts Arena's lorcaserin MAA for weight control

Promising results from Esperion ETC-1002 Phase 2 clinical trial for dyslipidemia

Switch may release fuel and materials for rapid growth and formation of layers that later become organs

ETC-1002 drug reduces LDL cholesterol levels in hypercholesterolemic patients

High-fat, low-carb foods linked with increased risk of heart attack in obese people

Long daily sedentary periods cause a health risk despite physical activity

Innovation in neuroscience drug discovery - eBook eBook

Leveraging the Radian ASAP in standard casework

A journey through science, software, and innovation: Insights from the Bruker software team

CellVoyant's AI-Powered Vision for the Future of Cell Therapy